MoneyWeek’s comprehensive guide to this week’s share tips

Three to buy

Cambridge Cognition

The Sunday Times

We’re living longer, but “our brains can’t always keep up”. Cambridge Cognition makes specialist software for tasks assessing brain health during clinical trials. The company is a “tiddler” with a market cap of just £35m, but revenues rose 50% to £10.1m last year when it signed up more clinical-trial contracts than at any time in its history. It also turned a “very modest” profit and now has a “decent cushion